Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Moore

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Obstetrics and Gynecology|July 22, 2011
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic massRichard G Moore, M Craig Miller, Paul Disilvestro, et al.
Gynecologic Oncology|April 18, 2019
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?Richard G Moore, Alexandra Blackman, M Craig Miller, et al.
International Journal of Oncology|March 18, 2015
The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cellsYifei Wang, Alex Han, Eva Chen, et al.
International Journal of Oncology|August 10, 2022
[Corrigendum] The cranberry flavonoids PAC DP‑9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cellsYifei Wang, Alex Han, Eva Chen, et al.
Human Pathology|November 4, 2011
The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 casesM Ruhul Quddus, C James Sung, Cunxian Zhang, et al.
International Journal of Oncology|September 17, 2011
Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cellsKyu Kwang Kim, Ajay P Singh, Rakesh K Singh, et al.
The Analyst|September 27, 2013
Simple enrichment and analysis of plasma lysophosphatidic acidsJialu Wang, Martha Sibrian-Vazquez, Jorge O Escobedo, et al.
American Journal of Obstetrics and Gynecology|February 18, 2014
A chemoresponse assay for prediction of platinum resistance in primary ovarian cancerThomas C Krivak, Shashikant Lele, Scott Richard, et al.
American Journal of Obstetrics and Gynecology|January 31, 2012
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disordersRichard G Moore, Michael Craig Miller, Margaret M Steinhoff, et al.
International Journal of Oncology|October 14, 2011
Purified cranberry proanthocyanidines (PAC-1A) cause pro-apoptotic signaling, ROS generation, cyclophosphamide retention and cytotoxicity in high-risk neuroblastoma cellsAjay P Singh, Thilo S Lange, Kyu K Kim, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Obstetrics and Gynecology|July 22, 2011
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic massRichard G Moore, M Craig Miller, Paul Disilvestro, et al.
Gynecologic Oncology|April 18, 2019
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?Richard G Moore, Alexandra Blackman, M Craig Miller, et al.
International Journal of Oncology|March 18, 2015
The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cellsYifei Wang, Alex Han, Eva Chen, et al.
International Journal of Oncology|August 10, 2022
[Corrigendum] The cranberry flavonoids PAC DP‑9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cellsYifei Wang, Alex Han, Eva Chen, et al.
Human Pathology|November 4, 2011
The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 casesM Ruhul Quddus, C James Sung, Cunxian Zhang, et al.
International Journal of Oncology|September 17, 2011
Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cellsKyu Kwang Kim, Ajay P Singh, Rakesh K Singh, et al.
The Analyst|September 27, 2013
Simple enrichment and analysis of plasma lysophosphatidic acidsJialu Wang, Martha Sibrian-Vazquez, Jorge O Escobedo, et al.
American Journal of Obstetrics and Gynecology|February 18, 2014
A chemoresponse assay for prediction of platinum resistance in primary ovarian cancerThomas C Krivak, Shashikant Lele, Scott Richard, et al.
American Journal of Obstetrics and Gynecology|January 31, 2012
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disordersRichard G Moore, Michael Craig Miller, Margaret M Steinhoff, et al.
International Journal of Oncology|October 14, 2011
Purified cranberry proanthocyanidines (PAC-1A) cause pro-apoptotic signaling, ROS generation, cyclophosphamide retention and cytotoxicity in high-risk neuroblastoma cellsAjay P Singh, Thilo S Lange, Kyu K Kim, et al.
Pageof 12